SAT0590 Long-term efficacy and safety of adalimumab by aetiologyin patients with non-infectious uveitis in the visual iii trial

Abstract

ObjectivesTo evaluate the long-term safety and efficacy of adalimumab in patients with non-infectious intermediate, posterior, or panuveitis, across different disease etiologies.MethodsAdult patients in the Phase III VISUAL I/II trials, who...